Glucose metabolism and function of CD4 Tregs are regulated by the TLR8/mTOR signal in an environment of SKOV3 cell growth.

PURPOSE

To investigate the role of mammalian target of rapamycin (mTOR) signal in Toll-like receptor (TLR) 8-mediated regulation of glucose metabolism and its effect on reversing immunosuppression in CD4 regulatory T-cells (Tregs) in ovarian cancer (OC).

METHODS

Fluorescence-activated cell sorting was used to detect the expression levels of mTOR and 4E-BP1 cells in CD4 Tregs. The prognosis and immune infiltration analysis of mTOR mRNA in OC were performed using the TIMER and Kaplan-Meier plotter database. Furthermore, real-time polymerase chain reaction (RT-PCR) and western blot (WB) were used to detect expression levels of glucose metabolism-related genes and proteins in CD4 Tregs. Glucose uptake and glycolysis levels were detected by colorimetry, while the effects of CD4 Tregs on the proliferation of CD4 T-effector cells (Teffs) were evaluated by carboxyfluorescein diacetate succinimidyl ester (CFSE).

RESULTS

mTOR expression in CD4 Tregs was significantly higher in patients with OC compared with controls and in CD4 Tregs than in CD4 Teffs in OC. Additionally, the expression level of mTOR mRNA was related to prognosis and immune infiltration levels in patients with OC. Blocking the mTOR signal resulted in downregulation of glucose metabolism in CD4 Tregs. Simultaneous inhibition of the mTOR signal while activation of the TLR8 signal had a coordinated inhibitory effect on glucose metabolism and the immunosuppressive function of CD4 Tregs. Furthermore, the mTOR signal played an essential role in TLR8-mediated reversal of immunosuppressive function in CD4 Tregs.

CONCLUSION

These findings imply that activation of the TLR8 signal inhibits glucose metabolism in CD4 Tregs by downregulating mTOR signaling, thereby reversing the immunosuppressive function of these cells in an OC cell growth environment.